Varför föredras 8011 -legering för farmaceutiska blisterförpackningar?
8011 offers superior formability with 25-30% elongation for deep-drawn cavities. Its high purity (99.3% Al) meets FDA 21 CFR requirements for drug contact. The alloy's Fe/Si composition prevents pinhole defects during foil rolling. It maintains barrier properties against Fukt- och syregenomträngning . Typisk tjocklek sträcker sig från 20-50 μm för optimalt skydd.
Hur jämför 8011 med 8021 för blisterförpackningar?
8011 has 15% higher tensile strength (145MPa vs 125MPa in 8021) for better puncture resistance. Both alloys share similar corrosion resistance in pH 4-8 environments. 8011's slightly higher iron content improves heat seal consistency at 180-220℃. 8021 is preferred for ultra-thin (<15μm) applications due to lower hardness. EU Pharmacopeia approves both for sterile packaging.
Vilka ytbehandlingar förbättrar 8011s farmaceutiska prestanda?
Elektrokemisk polering minskar ytråheten till<0.8μm Ra for cleanability. Chromate-free passivation (e.g., TCPO) improves corrosion resistance. PVdC or acrylic lacquer coatings enable cold-form blister processing. Laser etching creates micro-textures for improved lidding adhesion. All treatments must pass ISO 10993-1 biocompatibility tests.
Vilka är de viktigaste kvalitetstesterna för 8011 blisterfolie?
Pinhole -inspektion kräver<3 defects/m² under 2000lx backlighting. Thickness tolerance must be ±5% across rolls. Residual solvents are limited to <2mg/m² per USP <661>. Burst -styrka överskrider 1 . 5KPa för 40μm folie . DSC -analys verifierar termisk stabilitet upp till 300 grader.
Hur stöder 8011 hållbarhet i läkemedelsförpackningar?
Its 100% recyclability aligns with WHO's AMR packaging guidelines. Foil production consumes 60% less energy than plastic alternatives. Lightweighting to 25μm reduces material use by 20% versus legacy 50μm. Post-consumer recycled content can reach 30% without performance loss. Lifecycle assessments show 45% lägre kolavtryck än multi-lagers plast .
